Social Data for Pharmas: High-Volume, High-Value and Definitely Not Just for Marketers [Infographic] Posted June 2, 2016The continuing and dramatic growth of social media data streams has put a new tool in the hands of pharmaceutical companies – and not just marketers. Pharmacovigilance and drug safety teams are starting to leverage the power of social media to more effectively conduct post-marketing surveillance. R&D and innovation groups are turning to social media for new insights into unmet needs and to identify candidates for drug repositioning and repurposing. Check out our new infographic – Social Data for Pharmas: High-Volume, High-Value and Definitely Not Just for Marketers – for a perspective on the “state of social media in pharma.” And don’t miss our other posts on social-related topics: Innovation: Planned vs. Accidental Social Media and Pharmacovigilance: Six Studies That Show What’s Possible Is It Time to Jump on the Social Media Bandwagon?